A Nasal Vaccine Candidate, Containing Three Antigenic Regions from SARS-CoV-2, to Induce a Broader Response.

Vaccines (Basel) · 2024 · PMC11209543 · PMID 38932317

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

As shown in Figure 3 d, only the group intranasally inoculated with S2NDH + ODN-39M exhibited 100% response, with a clear trend to develop a higher IFN-γ secretion level. 3.3.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.